Tags: Coronavirus | Russia | russia | covid19 | vaccine | trials

Russia Completes Early Trials of 2nd Potential COVID-19 Vaccine

covid vaccine
(Siam Pukkato/Dreamstime.com)

Tuesday, 08 September 2020 07:07 AM

Siberia's Vector virology institute on Tuesday completed early-stage human trials, known as Phase II, of a second potential Russian vaccine against COVID-19, the state consumer safety watchdog was cited by the Interfax news agency as saying.

Russia registered its first vaccine candidate, developed by Moscow's Gamaleya Institute, in August. Late-stage trials of this vaccine, due to involve 40,000 participants, were launched last week.

Human trials of the second potential COVID-19 vaccine, a peptide-based jab, began on July 27 and involved a group of 100 volunteers, Interfax cited watchdog Rospotrebnadzor as saying.

"Today...the final group of 20 volunteers was released from hospital," said in a statement. "All 100 volunteers were vaccinated with two doses and have completed a 23-day monitoring period in hospital. The volunteers are feeling good."

Results are due to be published on Sept. 30, Interfax said. 

© 2020 Thomson/Reuters. All rights reserved.


   
1Like our page
2Share
GlobalTalk
Siberia's Vector virology institute on Tuesday completed early-stage human trials, known as Phase II, of a second potential Russian vaccine against COVID-19, the state consumer safety watchdog was cited by the Interfax news agency as saying.Russia registered its first...
russia, covid19, vaccine, trials
138
2020-07-08
Tuesday, 08 September 2020 07:07 AM
Newsmax Media, Inc.
 
 

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved